Caris Life Sciences, Inc. Common Stock (CAI) — Working Capital to Net Assets Ratio
Caris Life Sciences, Inc. Common Stock (CAI) has a Working Capital to Net Assets ratio of 146.4% as of June 2026. Working capital of $866.39 Million (current assets of $1.06 Billion minus current liabilities of $191.44 Million) is measured against net assets of $591.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Caris Life Sciences, Inc. Common Stock defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Caris Life Sciences, Inc. Common Stock Working Capital to Net Assets (2005–2025)
This chart shows how Caris Life Sciences, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 146.4%, reflecting working capital of $866.39 Million against net assets of $591.73 Million USD. For the complete balance sheet picture, see Caris Life Sciences, Inc. Common Stock total assets.
Annual Working Capital to Net Assets for Caris Life Sciences, Inc. Common Stock (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Caris Life Sciences, Inc. Common Stock from 2005 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check CAI cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 150.8% | $870.65 Million | $577.31 Million | $997.80 Million | $127.14 Million | ▲ +152.8 pp |
| 2024 | -2.0% | $50.31 Million | $-2.50 Billion | $215.73 Million | $165.42 Million | ▲ +4.9 pp |
| 2023 | -6.9% | $147.47 Million | $-2.14 Billion | $242.61 Million | $95.14 Million | ▲ +15.4 pp |
| 2022 | -22.3% | $379.14 Million | $-1.70 Billion | $516.04 Million | $136.91 Million | ▼ -7.2 pp |
| 2020 | -15.0% | $-105.59 Million | $702.24 Million | $214.66 Million | $320.25 Million | ▼ -45.6 pp |
| 2019 | 30.5% | $211.72 Million | $693.24 Million | $499.13 Million | $287.41 Million | ▲ +59.9 pp |
| 2018 | -29.3% | $-205.51 Million | $701.13 Million | $220.02 Million | $425.53 Million | ▼ -8.1 pp |
| 2017 | -21.2% | $-119.59 Million | $563.85 Million | $140.34 Million | $259.93 Million | ▼ -14.9 pp |
| 2016 | -6.3% | $-28.85 Million | $457.50 Million | $135.15 Million | $164.01 Million | ▲ +9.7 pp |
| 2015 | -16.0% | $-73.77 Million | $461.26 Million | $144.11 Million | $217.88 Million | ▲ +7.6 pp |
| 2014 | -23.6% | $-104.39 Million | $442.90 Million | $144.80 Million | $249.19 Million | ▼ -17.3 pp |
| 2013 | -6.3% | $-25.98 Million | $415.13 Million | $130.97 Million | $156.94 Million | ▼ -2.9 pp |
| 2012 | -3.4% | $-11.66 Million | $346.85 Million | $95.11 Million | $106.78 Million | ▼ -1.7 pp |
| 2011 | -1.7% | $-4.15 Million | $248.74 Million | $74.90 Million | $79.05 Million | ▲ +41.6 pp |
| 2010 | -43.3% | $-85.51 Million | $197.67 Million | $68.65 Million | $154.16 Million | ▼ -62.6 pp |
| 2009 | 19.3% | $24.93 Million | $129.10 Million | $63.38 Million | $38.45 Million | ▼ -12.1 pp |
| 2008 | 31.4% | $35.75 Million | $113.79 Million | $80.99 Million | $45.24 Million | ▲ +33.9 pp |
| 2007 | -2.4% | $-3.20 Million | $131.15 Million | $53.43 Million | $56.63 Million | ▲ +62.6 pp |
| 2006 | -65.0% | $-18.05 Million | $27.75 Million | $59.52 Million | $77.56 Million | ▼ -54.2 pp |
| 2005 | -10.8% | $-3.58 Million | $32.99 Million | $41.40 Million | $44.97 Million | — |